H1N1 (swine flu) & the R&D-based Pharmaceutical Industry

Statement 9 Jun 2026

UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)

IFPMA statement at the UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR) in New York on 9 June. We share the same objective: a world better prepared to prevent, prepare for, detect, and respond to pandemics. Industry is a core part of that system, engaging in strengthening the health of populations, developing vaccines...

Pharmaceutical industry’s response to the Ebola Bundibugyo virus disease outbreak

The latest Ebola Bundibugyo outbreak in Democratic Republic of Congo, Uganda, and neighbouring countries is deeply concerning. Pharmaceutical and biotech companies are working with global partners in a coordinated response. Accelerating the response As the scientific, humanitarian, and global health response accelerates to contain the outbreak, pharmaceutical companies remain central to these efforts. While no...

79th World Health Assembly (WHA79): Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement

On 18 May 2026, IFPMA delivered a statement on the Open-Ended Intergovernmental Working Group on the WHO Pandemic Agreement at the 79th World Health Assembly in Geneva. The innovative pharmaceutical industry remains a critical partner in pandemic preparedness and response, with a strong track record of action during pandemics and Public Health Emergencies of International...